Jeffrey Cannon Cilley, MD

Dr. Cilley is a board-certified medical oncologist and hematologist. He was named the chief medical resident of internal medicine during his residency at Northwestern Memorial Hospital and was the recipient of the Compassionate Care Award. In addition, Dr. Cilley is an assistant professor of medicine at Rush University. Dr Cilley is attending physician with Swidish Covenent Hospital.

Please follow the link below to find out more about Swidish Covenent Hospital.

Swidish Covenent Hospital


1.) Cilley J, Rihn C, Monreal J, Gordon LI, Sighal s, Tallman M, Williams S, Winter J, Mehta J. Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation? Bone Marrow Transplant. 2004 Jan; 33(2):161-4.
2.) Rihn C, Cilley J, Nail P, Pedicano AV, Mehta J. Definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantation. Haematologica. 2004 Jun; 89(6):763-4.
3.) Cilley J, Winter J. Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas. Haematologica. 2006 Jan; 91(1):113-20.
4.) Cilley J, Mulcahy M. Adjuvant therapy for colon cancer. Current Oncology Reports. 2006 May; 8(3):161-6.
5.) Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. British Journal of Haematology. 2007 Jun; 137(6):545-52.
6.) Robin J, Fintel B, Pikovskaya O, Davidson C, Cilley J, Flaherty J. Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literature. Journal of Medical Case Reports. July 2008 ;2(1): 229-6.
7.) Cilley J, Barfi K, Benson A, Mulcahy M. Bevacizumab in the treatment of colorectal cancer. Expert Opinion Biologic Therapy. May 2007 ;7(5): 739-749. 8.) Inwards D, Cilley J, Winter J. Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma. Best Practice and Research Clinical Haematology. Dec 2006; 19(4): 669-84.
9.) Cilley J, Winter J. A phase I/II Trial of combined weekly bortezomib and Y-90-ibritumomab tiuxetan (zevalin) in patients with relapsed or refractory follicular lymphoma. Lurie Comprehensive Cancer Center and Northwestern University Clinical Research Trial. 2007.